Literature DB >> 30614131

Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis.

Ikram Sghaier1, Etienne Brochot2,3, Besma Y Loueslati4, Wassim Y Almawi1,5.   

Abstract

HCV has been associated with a pro-inflammatory state, which predisposes to hepatocellular carcinoma (HCC). However, the different molecular mechanisms underlying the effect of HCV infection on HCC progression remain unclear. Although HCV infection illustrates the potential role of host genetics in the outcome of infectious diseases, there is no clear overview of some single nucleotide polymorphisms (SNPs) influencing spontaneous or treatment-induced HCV eradication. We studied the possible role of HCV infection in the processes of HCC initiation and performed a systematic analysis using data mining approaches to identify host polymorphisms associated with treatment response and HCC development using topological analysis of protein-proteins interactions (PPI) networks. On the basis of our analysis performed, we identified key hub proteins related to HCV-treatment response infection and to HCC development. Host genetic polymorphisms, such as inosine triphosphatase (ITPA), interferon, lambda 3 (IFNL3), Q5 interferon, lambda 4 (IFNL4), toll-like receptors (TLRs) and interferon-stimulated gene 15 (ISG-15), were identified as key genes for treatment prediction and HCC evolution. By comparing unique genes for HCV-treatment response and genes particular to HCV-HCC development, we found a common PPI network that may participate in more extensive signalling processes during anti-HCV treatment, which can play important roles in modulating the immune response to the occurrence of HCC. Data mining is an effective tool for identifying potential regulatory pathways involved in treatment response and HCC development. Our study may contribute to a better understanding of HCV immunopathogenesis and highlights the complex role of host genetics in HCV clearance.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  DAA; HCC; HCV; PPI

Mesh:

Year:  2019        PMID: 30614131     DOI: 10.1002/rmv.2033

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  3 in total

1.  Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study.

Authors:  Ahmed Kamal; Amr Aly Abd Elmoety; Yousri Abdelmeguid Rostom; Mohamed Said Shater; Sameh Aldesoky Lashen
Journal:  Clin Exp Hepatol       Date:  2021-03-11

Review 2.  Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate.

Authors:  Ahmed Kamal; Ahmed Elsheaita; Mahmoud Abdelnabi
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

3.  From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis.

Authors:  Jihad Aljabban; Nilay Danis; Merve Gurakar; Kamal Khorfan; Nabeal Aljabban; Cem Simsek; Hussam Salhi; Maryam Panahiazar; Dexter Hadley; Ahmet Gurakar; Behnam Saberi
Journal:  Hepatol Forum       Date:  2020-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.